eIF4E Threshold Levels Differ in Governing Normal and Neoplastic Expansion of Mammary Stem and Luminal Progenitor cells

Por Avdulov, Svetlana, Herrera, Jeremy, Smith, Karen, Peterson, Mark, Gomez-Garcia, Jose R., Beadnell, Thomas C., Schwertfeger, Kathryn L., Benyumov, Alexey O., Manivel, J. Carlos, Li, Shunan, Bielinsky, Anja-Katrin, Yee, Douglas, Bitterman, Peter B., Polunovsky, Vitaly A.
Publicado no Cancer Res (2014)

Phase I/II study of rilotumumab (AMG 102), an HGF inhibitor, and erlotinib in patients with advanced non-small cell lung cancer

Por Tarhini, Ahmad A, Rafique, Imran, Floros, Theofanis, Tran, Phu, Gooding, William, Villaruz, Liza, Burns, Timothy, Friedland, David, Petro, Daniel, Farooqui, Mariya, Gomez-Garcia, Jose, Gaither-Davis, Autumn, Dacic, Sanja, Argiris, Athanassios, Socinski, Mark A, Stabile, Laura P., Siegfried, Jill M.
Publicado no Cancer (2017)